We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Dave Fornell | May 09, 2023 | Cardiovascular Business | Cardiac Imaging
Cardiovascular Business spoke with two experts in cardiac imaging to identify some key trends at the American College of Cardiology (ACC) 2023 meeting. Marcelo DiCarli, MD, chief of the division of nuclear medicine and molecular imaging and executive director for the cardiovascular imaging program at Brigham and Women’s Hospital, and Rob Beanlands, MD, director of the National Cardiac PET Centre at the University of Ottawa Heart Institute in Canada, shared their thoughts.
DiCarli, who is also the chair of the ACC Cardiovascular Imaging Leadership Council, said clinical evidence has helped specialists craft guidelines in recent years that detail how imaging modalities can be used to best to help various types of patients. Cardiac computed tomography (CT) in particular has seen a large amount of growth, and this has been accelerated with its inclusion in the 2021 chest pain guidelines.